Authors: Sidwell, RW Smee, DF Huffman, JH Barnard, DL Morrey, JD Bailey, KW Feng, WC Babu, YS Bush, K

Citation: Rw. Sidwell et al., Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, ANTIVIR RES, 51(3), 2001, pp. 179-187

Authors: Sidwell, RW Smee, DF Huffman, JH Barnard, DL Bailey, KW Morrey, JD Babu, YS

Citation: Rw. Sidwell et al., In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIM AG CH, 45(3), 2001, pp. 749-757

Authors: Morrey, JD Bailey, KW Korba, BE Sidwell, RW

Citation: Jd. Morrey et al., Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine, ANTIVIR RES, 42(2), 1999, pp. 97-108

Authors: Jackson, MK Mitchell, EA Winslow, SG Okelberry, KM Sidwell, RW Morrey, JD

Citation: Mk. Jackson et al., Resistance to friend leukemia virus in transgenic mice expressing the native FV-4 gene, ACT VIROLOG, 43(1), 1999, pp. 19-23

Authors: Morrey, JD Korba, BE Sidwell, RW

Citation: Jd. Morrey et al., Transgenic mice as a chemotherapeutic model for hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 161-170